Jin Cheul Kim

Jin Cheul Kim is a notable inventor based in Eunpyeong-gu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral solid formulations. With a total of 4 patents to his name, Kim's work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of his latest patents is an oral solid formulation containing irinotecan and a method of preparing the same. This formulation includes irinotecan or a pharmaceutically acceptable salt thereof as an active ingredient, along with an acidifying agent. Another significant patent is a composite formulation for oral administration comprising ezetimibe and rosuvastatin. This solid composite formulation includes ezetimibe granules with a specific particle size distribution and a rosuvastatin mixture-part, along with a method of preparing the composite formulation.

Career Highlights

Jin Cheul Kim is currently associated with Hanmi Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective drug formulations that can enhance patient outcomes.

Collaborations

Kim collaborates with talented individuals in his field, including Yong Il Kim and Jae Hyun Park. Their combined expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Jin Cheul Kim's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in drug formulation and delivery.

This text is generated by artificial intelligence and may not be accurate.